| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 1,495,170 | 2,289,296 | 2,231,033 | | Cost of Revenue | 1,049,785 | 1,553,994 | 1,470,554 | | | Gross Profit | 445,385 | 735,302 | 760,479 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 523,136 | 757,842 | 685,438 | | Non Recurring | 20,638 | 163,852 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (98,389) | (186,392) | 75,041 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 299 | 1,362 | 7,023 | | Earnings Before Interest And Taxes | (98,090) | (185,030) | 82,064 | | Interest Expense | 20,589 | 35,927 | 31,542 | | Income Before Tax | (118,679) | (220,957) | 50,522 | | Income Tax Expense | 20,842 | (32,116) | 18,946 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (139,521) | (188,841) | 31,576 | | | Non-recurring Events | | Discontinued Operations | (416,138) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (555,659) | (188,841) | 31,576 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($555,659) | ($188,841) | $31,576 |
|
1.48% Nasdaq 
Income Statement
